Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. 2017-01-05
Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris. 2017-01-04
Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY. 2017-01-03
Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY. 2017-01-03
Pharnext S.A.. (1/3/17). "Press Release: Pharnext Announces the Amendment to the Liquidity Contract with French Broker Gilbert Dupont and the Annual Update on Its Liquidity Agreement". Paris. 2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. 2017-01-02
OSE Immunotherapeutics S.A.. (12/28/16). "Press Release: OSE Immunotherapeutics Signs a License Option Agreement with Servier to Develop and Commercialize the Product Effi-7". Nantes & Paris. 2016-12-28
Genticel S.A.. (12/22/16). "Press Release: Genticel and Genkyotex Announce Intention to Enter into Strategic Combination [Not for Australia, Canada, Japan, New Zealand, South Africa, or the United States]". Toulouse & Geneva. 2016-12-22
Pharnext S.A.. (12/20/16). "Press Release: Pharnext Completes Patient Enrollment in International Pivotal Phase 3 Trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1A". Paris. 2016-12-20
Innate Pharma S.A.. (12/19/16). "Press Release: Innate Pharma Announces Key Leadership and Corporate Governance Changes to Support Next Stage of Development". Marseille. 2016-12-19
Novacyt S.A.. (12/15/16). "Press Release: Novacyt Successfully Completes €2.7m Fundraising". Paris & Cambridge. 2016-12-15
Cellectis S.A.. (12/15/16). "Press Release: Cellectis Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of UCART123 Phase 1 Study Protocols in AML and BPDCN". New York, NY. 2016-12-15
Valneva S.E.. (12/15/16). "Press Release: Valneva Confirms Closing of Private Placement in Connection with €15.2m Investment by MVM Life Science Partners". Lyon. 2016-12-15
Abivax S.A.. (12/15/16). "Press Release: Abivax Appoints Didier Blondel as Chief Financial Officer". Paris. 2016-12-15
TxCell S.A.. (12/14/16). "Press Release: TxCell Provides Update on Its Strengthened IP Portfolio". Valbonne. 2016-12-14
Genticel S.A.. (12/13/16). "Press Release: Genticel Reports Final Results of GTL001 Phase 2 Trial in HPV16/18-infected Women". Paris & Toulouse. 2016-12-13
Sanofi S.A.. (12/8/16). "Press Release: Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent (dupilumab) Accepted for Review by the EMA". Paris & Tarrytown, NY. 2016-12-08
TxCell S.A.. (12/8/16). "Press Release: TxCell Signs In-licensing Global Agreement with Inserm Transfert for Novel Population of Regulatory T Cells". Valbonne & Nantes. 2016-12-08
Transgene S.A.. (12/7/16). "Press Release: UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)". Strasbourg. 2016-12-07
Lysogene S.A.. (12/7/16). "Press Release: Lysogene Appoints David Schilansky to Board of Directors". Paris. 2016-12-07
Biomunex Pharmaceuticals SASU. (12/5/16). "Press Release: Biomunex Appoints Dr. Sebastian Amigorena and Dr. Dragan Grabulovski as Key Scientific and Strategic Advisors". Paris. 2016-12-05
Oncodesign S.A.. (12/1/16). "Press Release: Oncodesign Completes the Acquisition of François Hyafil Research Centre and Appoints Two New Strategic Activity Directors". Dijon. 2016-12-01
Theradiag S.A.. (12/1/16). "Press Release: US Launch of the Fifth Test in the LISA Tracker Range". Croissy-Beaubourg & Montpellier. 2016-12-01
Valneva S.E.. (12/1/16). "Press Release: Leading Healthcare Investor MVM Life Science Partners Acquires 7.5% Shareholding in Valneva". Lyon. 2016-12-01
Genticel S.A.. (11/30/16). "Press Release: Genticel Successfully Completes Determining Milestone in Partnership with Serum Institute Regarding Use of GTL003 in Multivalent Vaccines". Paris & Toulouse. 2016-11-30
TxCell S.A.. (11/29/16). "Press Release: TxCell Completes Aligning Operations with Strategic Refocus. Resources Now Focused on Promising CAR-Treg Programs". Valbonne. 2016-11-29
Carbios S.A.. (11/28/16). "Press Release: Carbios – New Success with the Development of a Depolymerization Process at 100% of Plastic Bottles". Clermont-Ferrand. 2016-11-28
Neovacs S.A.. (11/23/16). "Press Release: Neovacs Signs Production Partnership with 3P Biopharmaceuticals, a Leading GMP Producer of Biological Drugs". Paris & Boston, MA. 2016-11-23
Cellectis S.A.. (11/22/16). "Press Release: Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016". New York, NY. 2016-11-22
Cellectis S.A.. (11/21/16). "Press Release: Cellectis to Participate in Oppenheimer Life Sciences Summit, NY and in Piper Jaffray 28th Annual Health Care Conference, NY". New York, NY. 2016-11-21
Novasep Holding S.A.S. (11/17/16). "Press Release: Novasep and Japanese Agent AR Brown Extend Partnership". Cambridge. 2016-11-17
Enterome Bioscience S.A.. (11/16/16). "Press Release: Bristol-Myers Squibb and Enterome SA Announce Immuno-oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules". New York, NY & Paris. 2016-11-16
Cellnovo. (11/16/16). "Press Release: Cellnovo Files for 510(k) Approval with the FDA for Its Mobile, Connected, All-in-one Diabetes Management System". Paris. 2016-11-16
Bruker Corporation. (11/16/16). "Press Release: Cetim Facility Receives Bruker Contour CMM Dimensional Analysis System". San José, CA & Senlis. 2016-11-16
Cellectis S.A.. (11/15/16). "Press Release: Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate – UCART123". New York, NY. 2016-11-15
Neovacs S.A.. (11/15/16). "Press Release: Neovacs Acquires Interferon alpha Manufacturing Technology from AmegaBiotech". Paris & Boston, MA. 2016-11-15
OSE Immunotherapeutics S.A.. (11/15/16). "Press Release: Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases". Geneva & Nantes. 2016-11-15
UroMems. (11/15/16). "Press Release: UroMems Closes €14m Financing to Develop Its Smart Artificial Urinary Sphincter to Market". Grenoble. 2016-11-15
Stallergenes Greer plc. (11/14/16). "Press Release: Collaboration with the Sean N. Parker Center at Stanford University". 2016-11-14
bioMérieux S.A.. (11/14/16). "Press Release: Business Review for the Nine Months Ended September 30, 2016". Marcy l’Étoile. 2016-11-14
bioMérieux S.A.. (11/10/16). "Press Release: bioMérieux Launches eMAG, a New Generation Automated System for the Extraction of DNA and RNA". Marcy l’Étoile. 2016-11-10
Valneva S.E.. (11/9/16). "Press Release: Valneva Reports Strong Business Performance in First Nine Months, Company Increases Financial Guidance for Full Year 2016". Lyon. 2016-11-09
TxCell S.A.. (11/8/16). "Press Release: TxCell – Financial information for the 3rd Quarter of 2016". Valbonne. 2016-11-08
bioMérieux S.A.. (11/7/16). "Press Release: Pierre Boulud Appointed Corporate Vice President of the Asia Pacific Region at bioMérieux". Marcy l’Étoile. 2016-11-07
Neovacs S.A.. (11/7/16). "Press Release: Neovacs Enrolls the First U.S. Patient in Phase IIb study of IFNa Kinoid for Treatment of Systemic Lupus Erythematosus (SLE)". Paris & Boston, MA. 2016-11-07
CorWave. (11/4/16). "Press Release: CorWave Raises $17.1 Million in Series B Financing". Paris. 2016-11-04
TxCell S.A.. (11/3/16). "Press Release: TxCell Announces the Issue of a Second Tranche of Convertible Notes of €2 Million as Planned as Part of the OCABSA Financing". Valbonne. 2016-11-03
Novasep Holding S.A.S. (11/3/16). "Press Release: Refinancing – Financial Information about Exchange Notes and Warrants". Lyon. 2016-11-03
Neovacs S.A.. (11/3/16). "Press Release: Neovacs to Attend Jefferies 2016 London Healthcare Conference November 16 & 17, 2016". Paris & Boston, MA. 2016-11-03
Sanofi S.A.. (10/28/16). "Press Release: Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis". Paris & Tarrytown, NY. 2016-10-28
Sanofi S.A.. (10/28/16). "Press Release: Sanofi Announces Strong Q3 2016 Results". Paris. 2016-10-28
PathoQuest S.A.S.. (10/27/16). "Press Release: PathoQuest Achieves CE Mark for the iDTECT Blood Test". 2016-10-27
Onxeo S.A.. (10/27/16). "Press Release: Onxeo Announces Promising Results from Preclinical Study of Beleodaq Combination with Checkpoint Inhibitors". Paris & Copenhagen. 2016-10-27
Erytech Pharma. (10/27/16). "Press Release: Erytech Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer". Lyon. 2016-10-27
Novasep Holding S.A.S. (10/26/16). "Press Release: Novasep Anounces the Success of Its Refinancing". Lyon. 2016-10-26
Onxeo S.A.. (10/25/16). "Press Release: Onxeo Reports Third Quarter 2016 Financial Information and Provides Business Update". Paris & Copenhagen. 2016-10-25
TxCell S.A.. (10/19/16). "Press Release: TxCell and University of British Columbia Start Collaboration to Develop CAR-Tregs in Solid Organ Transplantation". Valbonne. 2016-10-19
bioMérieux S.A.. (10/17/16). "Press Release: Lyme Disease Diagnostic Tests". Marcy l’Étoile. 2016-10-17
IntegraGen S.A.. (10/14/16). "Press Release: IntegraGen Reports Revenues for First Half of 2016". Évry. 2016-10-14
TxCell S.A.. (10/13/16). "Press Release: TxCell Appoints Dr. Li Zhou as Vice President Cell Engineering to Lead Its CAR-Treg Programs". Valbonne. 2016-10-13
Neovacs S.A.. (10/12/16). "Press Release: Neovacs Signs a Cooperation Agreement with the Department of Diabetes at the Reputed Hospital Cochin in Paris". Paris. 2016-10-12
Scienion AG. (10/12/16). "Press Release: Scienion Opens French Subsidiary Cellenion with Focus on Controlled Cell Dispensing Technologies". Berlin & Lyon. 2016-10-12
Transgene S.A.. (10/11/16). "Press Release: Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study". Strasbourg. 2016-10-11
IntegraGen S.A.. (10/10/16). "Press Release: New Data on IntegraGen’s miR-31-3p Biomarker Featured in Presentation at 2016 ESMO Congress". Copenhagen. 2016-10-10
bioMérieux S.A.. (10/10/16). "Press Release: BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi Join Forces against Sepsis". 2016-10-10
Onxeo S.A.. (10/10/16). "Press Release: Onxeo to Present at the 15th Annual BIO Investor Forum in San Francisco". Paris & Copenhagen. 2016-10-10
Genfit S.A.. (10/6/16). "Press Release: Genfit Successfully Raises EUR 33.9 Million in Private Placement [Not for United States, Canada, Australia or Japan]". Lille & Cambridge, MA. 2016-10-06
Advanced Accelerator Applications S.A.. (10/5/16). "Press Release: Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares". New York, NY. 2016-10-05
Mayoly Spindler. (10/5/16). "Press Release: Mayoly Spindler Acquires the Swedish Laboratory Kibion". Paris. 2016-10-05
PX’Therapeutics S.A.. (10/5/16). "Press Release: PX’Therapeutics and Relief Therapeutics Holding AG Announce a Strategic Collaboration Agreement for the Recombinant Production of Atexakin Alfa". Grenoble & Geneva. 2016-10-05
Genfit S.A.. (10/5/16). "Press Release: Genfit Launches a Share Capital Increase through Private Placement [Not for United States, Canada, Australia or Japan]". Lille & Cambridge, MA. 2016-10-05
Cellectis S.A.. (10/4/16). "Press Release: Cellectis Announces the Issuance of U.S. Patent 9,458,439 Following U.S. Patent 8,921,332 Issued in December 2014". New York, NY. 2016-10-04
Genfit S.A.. (10/3/16). "Press Release: New Scientific Data to be Presented During Next AASLD Annual Meeting, Strong Involvement in the First-Ever NASH-TAG Conference". Lille & Cambridge, MA. 2016-10-03
Sanofi S.A.. (9/30/16). "Press Release: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare". Paris. 2016-09-30
Onxeo S.A.. (9/30/16). "Press Release: Onxeo Raises €12.5 Million through Capital Increase with US and European Investors [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen. 2016-09-30
Neovacs S.A.. (9/30/16). "Press Release: Half-year Results 2016 and Update on Operational Development". Paris. 2016-09-30
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
Onxeo S.A.. (9/29/16). "Press Release: Onxeo Launches Capital Increase [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen. 2016-09-29
Oncodesign S.A.. (9/28/16). "Press Release: GSK and Oncodesign Announce Agreement for Oncodesign’s Acquisition of GSK’s Research Centre in France". 2016-09-28
Noxxon Pharma N.V.. (9/28/16). "Press Release: Noxxon Pharma NV Lists Its Shares on Alternext Paris [Not for United States, Australia, Canada or Japan or any other jurisdiction where unlawful]". Berlin. 2016-09-28
Genfit S.A.. (9/27/16). "Press Release: Genfit Is Filing for IND Submission for New Indication of Elafibranor in Primary Biliary Cholangitis (PBC)". Lille & Cambridge, MA. 2016-09-27
Erytech Pharma. (9/26/16). "Press Release: Erytech Completes Patient Enrollment in Phase 2 Trial of Eryaspase (Graspa) for Pancreatic Cancer". Lyon. 2016-09-26
Sanofi S.A.. (9/26/16). "Press Release: Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA". Paris & Tarrytown, NY. 2016-09-26
Genfit S.A.. (9/26/16). "Press Release: H1 2016 Results. Cash Position at End of Period at €94m and Significatn Advances in Elafibranor Program". Lille & Cambridge, MA. 2016-09-26
Novasep Holding S.A.S. (9/26/16). "Press Release: Refinancing – Launch of an Exchange Offer and Consent Solicitation [This press release may not be published, forwarded or distributed, directly or indirectly, in the United States, Canada, Australia or Ja 2016-09-26
Global Bioenergies S.A.. (9/23/16). "Press Release: Establishment of Flexible Bond Financing by the Reserved Issue of OCABSAs for an €11.25 Million Bond Loan on Condition of Shareholder Approval". Évry & Dubai. 2016-09-23
Global Bioenergies S.A.. (9/22/16). "Press Release: Publication of the Half-year Results to 30/06/2016. Net Loss for the Group of €6.7 Million in the First Half of 2016 – €9.1 Million in Cash at 30 June 2016". Évry. 2016-09-22
Genticel S.A.. (9/22/16). "Press Release: Genticel Presents First Half 2016 Financial Results and Updates Its Operational Outlook". Paris & Toulouse. 2016-09-22
Polyplus-transfection S.A.. (9/19/16). "Press Release: ArchiMed Acquires Biotech Specialist Polyplus-transfection". 2016-09-19
Enterome Bioscience S.A.. (9/19/16). "Press Release: Enterome Appoints Christophe Bonny as Chief Scientific Officer". Paris & Cambridge, MA. 2016-09-19
Sanofi S.A.. (9/16/16). "Press Release: Sanofi Files Suit in U.S. to Defend Patent Rights on Lantus and Lantus Solostar". Paris. 2016-09-16
Novasep S.A.. (9/14/16). "Press Release: Novasep and Triclinic Labs Enter a Strategic Alliance for Solid-state Chemistry Services". Lyon. 2016-09-14
Sanofi S.A.. (9/13/16). "Press Release: Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone". Paris. 2016-09-13
Onxeo S.A.. (9/12/16). "Press Release: Onxeo Announces First Outcomes of Livatag Preclinical Plan". Paris & Copenhagen. 2016-09-12
Cellectis S.A.. (9/8/16). "Press Release: Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results". New York, NY. 2016-09-08
Innate Pharma S.A.. (9/8/16). "Press Release: First Half of 2016 – Building Momentum through Clinical Development and New Partnerships". 2016-09-08
Onxeo S.A.. (9/7/16). "Press Release: Combination of AsiDNA and PARP Inhibitors Demonstrates Synergistic Effect, Bypasses Genetic Restriction". Paris & Copenhagen. 2016-09-07
Onxeo S.A.. (9/7/16). "Press Release: Onxeo to Present at the 18th Annual Rodman and Renshaw Global Investment Conference in New York". Paris & Copenhagen. 2016-09-07
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top